Search results
Showing 646 to 660 of 2042 results for guidelines
This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.
Brunel University. During this time, Paul contributed to numerous NICE guidelines and was also a member of the technology appraisal...
An advisory service from the UK’s National Institute for Health and Care Excellence to help other countries improve their nation’s health and wellbeing
COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community (NG163)
This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.
Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are
Cellulitis and erysipelas: antimicrobial prescribing (NG141)
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.
May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COVID-19 see our guideline on managing COVID-19.
NICE's quick guide on recognising and preventing delirium
NICE quality improvement resource (QIR) for adult social care
This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.
In development [GID-NG10398] Expected publication date: TBC
Register an interest in this interventional procedure ...
Eculizumab for treating atypical haemolytic uraemic syndrome (HST1)
Evidence-based recommendations on eculizumab (Soliris) for treating atypical haemolytic uraemic syndrome in adults and children.
In development [GID-NG10431] Expected publication date: 26 March 2025
Good practice guidance – Integrated process statement (PMG12)
Good practice guidance – Integrated process statement